entertainment -WSS

entertainment

author：entertainment 2025-08-04 12:31:58 - browse：95

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Listen: A conversation with researcher Kevin Esvelt on biosecurity

WSS

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Hospitals look to new technology to keep health care workers safe

Weight loss drug costs may need more research, senator suggests

Weight loss drug costs may need more research, senator suggests

ASCO eve: Let’s set the table for this year's meeting

FDA's Woodcock to retire early next year

leisure time

entertainment

explore

As demand for Covid shots wanes, Moderna seeks its next success

Congress must reauthorize a committee to support older Americans

Hepatitis C has a cure — but many Americans still lack access to it

Why medical students are struggling with mental health

Guidelines to prevent youth baseball injuries need more muscle

World's first CRISPR

The high cost of giving birth even with insurance

H5N1 virus can be tracked in retail milk, scientists say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Digital health: a case of mistaken identity

leisure time

Ransomware attacks on hospitals: Study outlines patient impact

Reports of telehealth's death have been greatly exaggerated

FDA poised to publish guidelines for clinical trial diversity

Liver decline slowed by off

Eyeing GLP

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

hotspot

Wikipedia

hotspot

entertainment